Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells - PubMed (original) (raw)

Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells

R Moriggl et al. Mol Cell Biol. 1997 Jul.

Abstract

Stat (signal transducers and activators of transcription) and Jak (Janus kinases) proteins are central components in the signal transduction events in hematopoietic and epithelial cells. They are rapidly activated by various cytokines, hormones, and growth factors. Upon ligand binding and cytokine receptor dimerization, Stat proteins are phosphorylated on tyrosine residues by Jak kinases. Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes. Stat5 and Stat6 are transcription factors active in mammary epithelial cells and immune cells. Prolactin activates Stat5, and interleukin-4 (IL-4) activates Stat6. Both cytokines are able to stimulate cell proliferation, differentiation, and survival. We investigated the transactivation potential of Stat6 and found that it is not restricted to lymphocytes. IL-4-dependent activation of Stat6 was also observed in HC11 mammary epithelial cells. In these cells, Stat6 activation led to the induction of the beta-casein gene promoter. The induction of this promoter was confirmed in COS7 cells. The glucocorticoid receptor was able to further enhance IL-4-induced gene transcription through the action of Stat6. Deletion analysis of the carboxyl-terminal region of Stat6 and recombination of this region with a heterologous DNA binding domain allowed the delimitation and characterization of the transactivation domain of Stat6. The potencies of the transactivation domains of Stat5, Stat6, and viral protein VP16 were compared. Stat6 had a transactivation domain which was about 10-fold stronger than that of Stat5. In pre-B cells (Ba/F3), the transactivation domain of Stat6 was IL-4 regulated, independently from its DNA binding function.

PubMed Disclaimer

Similar articles

• Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules.
  Chida D, Wakao H, Yoshimura A, Miyajima A. Chida D, et al. Mol Endocrinol. 1998 Nov;12(11):1792-806. doi: 10.1210/mend.12.11.0196. Mol Endocrinol. 1998. PMID: 9817603
• Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription.
  Stoecklin E, Wissler M, Moriggl R, Groner B. Stoecklin E, et al. Mol Cell Biol. 1997 Nov;17(11):6708-16. doi: 10.1128/MCB.17.11.6708. Mol Cell Biol. 1997. PMID: 9343435 Free PMC article.
• Transcription factor regulation in mammary epithelial cells.
  Groner B. Groner B. Domest Anim Endocrinol. 2002 Jul;23(1-2):25-32. doi: 10.1016/s0739-7240(02)00142-x. Domest Anim Endocrinol. 2002. PMID: 12142223 Review.
• Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors.
  Groner B, Fritsche M, Stöcklin E, Berchtold S, Merkle C, Moriggl R, Pfitzner E. Groner B, et al. Growth Horm IGF Res. 2000 Apr;10 Suppl B:S15-20. doi: 10.1016/s1096-6374(00)80004-0. Growth Horm IGF Res. 2000. PMID: 10984248 Review.

Cited by

• STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
  Wong GL, Manore SG, Doheny DL, Lo HW. Wong GL, et al. Semin Cancer Biol. 2022 Nov;86(Pt 3):84-106. doi: 10.1016/j.semcancer.2022.08.003. Epub 2022 Aug 19. Semin Cancer Biol. 2022. PMID: 35995341 Free PMC article. Review.
• Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor.
  Goenka S, Boothby M. Goenka S, et al. Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4210-5. doi: 10.1073/pnas.0506981103. Epub 2006 Mar 6. Proc Natl Acad Sci U S A. 2006. PMID: 16537510 Free PMC article.
• Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5.
  Doppler W, Windegger M, Soratroi C, Tomasi J, Lechner J, Rusconi S, Cato AC, Almlöf T, Liden J, Okret S, Gustafsson JA, Richard-Foy H, Starr DB, Klocker H, Edwards D, Geymayer S. Doppler W, et al. Mol Cell Biol. 2001 May;21(9):3266-79. doi: 10.1128/MCB.21.9.3266-3279.2001. Mol Cell Biol. 2001. PMID: 11287629 Free PMC article.
• Establishing a novel and sensitive assay for bioactivity determination of anti-CD25 antibodies.
  Duan M, Yu C, Yang Y, Fu Z, Liu C, Du J, Li M, Guo S, Yu X, Xu G, Mei Y, Wang L. Duan M, et al. Heliyon. 2023 Jun 24;9(6):e17401. doi: 10.1016/j.heliyon.2023.e17401. eCollection 2023 Jun. Heliyon. 2023. PMID: 37416689 Free PMC article.
• Proteasome-dependent down-regulation of activated Stat5A in the nucleus.
  Chen Y, Dai X, Haas AL, Wen R, Wang D. Chen Y, et al. Blood. 2006 Jul 15;108(2):566-74. doi: 10.1182/blood-2005-12-4777. Epub 2006 Mar 28. Blood. 2006. PMID: 16569768 Free PMC article.

References

1. 1. Mol Cell Biol. 1991 Jul;11(7):3745-55 - PubMed
2. 1. Science. 1991 Nov 1;254(5032):707-10 - PubMed
3. 1. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3130-4 - PubMed
4. 1. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7836-9 - PubMed
5. 1. J Biol Chem. 1992 Nov 15;267(32):22752-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal